Viele C S, Moran T A
Department of Physiological Nursing, University of California, San Francisco.
Semin Oncol Nurs. 1993 Aug;9(3 Suppl 1):20-4.
Clinical trials have demonstrated that rIL-2 can be safely administered in an outpatient setting. A thorough nursing assessment ensures patient safety and effective toxicity management. Because it is becoming more economically advantageous to treat patients on an outpatient basis, nurses will need to become involved in all aspects of managed care. Outpatient administration of rIL-2 challenges nurses to be both technologically expert and clinically proficient.
临床试验表明，重组白细胞介素-2（rIL-2）可在门诊环境中安全给药。全面的护理评估可确保患者安全及有效的毒性管理。由于门诊治疗患者在经济上变得更具优势，护士将需要参与到管理式医疗的各个方面。rIL-2的门诊给药对护士提出了既要技术精湛又要临床精通的挑战。
